Literature DB >> 8784021

Major histocompatibility complex expression and lung ischemia-reperfusion in rats.

T K Waddell1, R M Gorczynski, K N DeCampos, G A Patterson, A S Slutsky.   

Abstract

BACKGROUND: Clinical studies in kidney and liver transplantation have suggested that poor early function is associated with increased graft loss due to rejection. Ischemia-reperfusion injury may contribute to rejection by enhancing graft immunogenicity.
METHODS: A rat model of unilateral in situ pulmonary ischemia-reperfusion was used to examine class II major histocompatibility complex (MHC) antigen expression. The effects of deflation during ischemia (which augments subsequent injury) as well as concurrent allostimulation were also examined. Major histocompatibility complex expression was examined 9 days after ischemia using the binding of radiolabeled anti-class II antibody and immunohistochemistry.
RESULTS: Four hours of ischemia in full inflation or 2 hours of atelectatic ischemia both led to severe lung injury. Ischemia-reperfusion injury led to greater MHC expression in the ischemic lung compared with the nonischemic side. Allostimulation with mononuclear cells did not increase MHC expression in the nonischemic lung but did enhance the increase found in the ischemic lung. This was not due to a graft-versus-host response because allostimulation with F1 cells also led to a significant increase.
CONCLUSIONS: Severe ischemic lung injury leads to significant increases in MHC expression, detectable after 9 days of reperfusion. Deflation during ischemia, which augments lung injury, also augments increased MHC expression. Concurrent allostimulation with foreign mononuclear cells appears to potentiate increased MHC expression after ischemia. Increases in graft MHC expression may enhance immunogenicity and increase the rejection response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784021     DOI: 10.1016/s0003-4975(96)00509-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Genomic profiling of kidney ischemia-reperfusion reveals expression of specific alloimmunity-associated genes: Linking "immune" and "nonimmune" injury events.

Authors:  D N Grigoryev; M Liu; C Cheadle; K C Barnes; H Rabb
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

2.  The effect of primary graft dysfunction on survival after lung transplantation.

Authors:  Jason D Christie; Robert M Kotloff; Vivek N Ahya; Gregory Tino; Alberto Pochettino; Christina Gaughan; Ejigayehu DeMissie; Stephen E Kimmel
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

Review 3.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

4.  Early immunological changes associated with laryngeal transplantation in a major histocompatibility complex-matched pig model.

Authors:  E Barker; P Murison; P Macchiarini; A Jones; C Otto; H-J Rothkoetter; K Haverson; M Bailey; M Birchall; C Stokes
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

Review 5.  The effects of apigenin administration on the inhibition of inflammatory responses and oxidative stress in the lung injury models: a systematic review and meta-analysis of preclinical evidence.

Authors:  Ali Rahimi; Mina Alimohammadi; Fatemeh Faramarzi; Reza Alizadeh-Navaei; Alireza Rafiei
Journal:  Inflammopharmacology       Date:  2022-06-04       Impact factor: 5.093

6.  Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.

Authors:  H J Huang; R D Yusen; B F Meyers; M J Walter; T Mohanakumar; G A Patterson; E P Trulock; R R Hachem
Journal:  Am J Transplant       Date:  2008-09-10       Impact factor: 8.086

7.  In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts.

Authors:  J-C Chang; J H Leung; T Tang; M G Hartwig; Z E Holzknecht; W Parker; R D Davis; S S Lin
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

Review 8.  Inflammatory response to pulmonary ischemia-reperfusion injury.

Authors:  Calvin S H Ng; Song Wan; Ahmed A Arifi; Anthony P C Yim
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

9.  Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).

Authors:  Michael Keller; Errol Bush; Joshua M Diamond; Pali Shah; Joby Matthew; Anne W Brown; Junfeng Sun; Irina Timofte; Hyesik Kong; Ilker Tunc; Helen Luikart; Aldo Iacono; Steven D Nathan; Kiran K Khush; Jonathan Orens; Moon Jang; Sean Agbor-Enoh
Journal:  J Heart Lung Transplant       Date:  2021-02-20       Impact factor: 13.569

10.  Length of pressure-controlled reperfusion is critical for reducing ischaemia-reperfusion injury in an isolated rabbit lung model.

Authors:  Stefan Guth; Diethard Prüfer; Thorsten Kramm; Eckhard Mayer
Journal:  J Cardiothorac Surg       Date:  2007-12-07       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.